Specific suppressor cells in graft–host tolerance of HLA-identical marrow transplantation
暂无分享,去创建一个
[1] K. Sullivan,et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. , 1981, Blood.
[2] R. Storb,et al. Cell-mediated immunity to non-HLA antigens of the host by donor lymphocytes in patients with chronic graft-vs-host disease. , 1980, Journal of immunology.
[3] H. Deeg,et al. Marrow Transplantation in Thirty "Untransfused" Patients with Severe Aplastic Anemia , 1980, Annals of Internal Medicine.
[4] R. Storb,et al. Nonspecific suppressor cells in patients with chronic graft-vs-host disease after marrow grafting. , 1979, Journal of immunology.
[5] P. Neiman,et al. Marrow transplantation for acute nonlymphoblastic leukemia in first remission. , 1979, The New England journal of medicine.
[6] I. Hilgert. The Involvement of Activated Specific Suppressor T Cells in Maintenance of Transplantation Tolerance , 1979, Immunological reviews.
[7] E. Reinherz,et al. Aberrations of suppressor T cells in human graft-versus-host disease. , 1979, The New England journal of medicine.
[8] K. Sullivan,et al. Analysis of late infections in 89 long-term survivors of bone marrow transplantation. , 1979, Blood.
[9] G. Shearer,et al. Human cytotoxic response in vitro to trinitrophenyl-modified autologous cells. I. T cell recognition of TNP in association with widely shared antigens. , 1978, Journal of immunology.
[10] G. Shearer,et al. Human cytotoxic response in vitro to trinitrophenyl-modified autologous cells. II. Diversity of self determinants recognized in association with TNP. , 1978, Journal of immunology.
[11] K. Sullivan,et al. Chronic cutaneous graft-versus-host disease in man. , 1978, The American journal of pathology.
[12] H. Ochs,et al. Does graft-versus-host disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation on 56 long-term survivors. , 1978, Blood.
[13] R. Storb,et al. Deposition of IgM and complement at the dermoepidermal junction in acute and chronic cutaneous graft-vs-host disease in man. , 1978, Journal of immunology.
[14] R. Storb,et al. Studies on cellular inhibition and serum-blocking factors in 28 human patients given marrow grafts from HLA identical siblings. , 1977, Journal of immunology.
[15] S. J. Baum,et al. Experimental Hematology Today , 1977, Experimental Hematology Today.
[16] R. Storb,et al. Infusion of donor lymphocytes into stable canine radiation chimeras: implications for mechanism of transplantation tolerance. , 1976, Journal of immunology.
[17] R. Storb,et al. Canine marrow transplantation: are serum blocking factors necessary to maintain the stable chimeric state? , 1975, Journal of immunology.
[18] G. Shearer,et al. Cell‐mediated cytotoxicity to trinitrophenyl‐modified syngeneic lymphocytes , 1974, European journal of immunology.